| Literature DB >> 16114185 |
Paloma Ropero1, Maria José Murga, Fernando A González, Marta Polo, Celina Benavente, María Salvador, Ana Villegas.
Abstract
Hb E-Saskatoon [beta22(B4)Glu-->Lys] does not cause any clinical symptoms in the heterozygous state. The homozygous state shows moderate phenotype expression. It has also been detected in association with beta-thalassemia. We present the first case of Hb E-Saskatoon associated with Hb Lepore-Baltimore. This unusual combination of mutations does not aggravate the clinical picture, as only microcytosis and hypochromia have been observed. Hb E-Saskatoon can only be correctly characterized by ion exchange high performance liquid chromatography (HPLC) or by DNA sequencing.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16114185 DOI: 10.1081/hem-200066321
Source DB: PubMed Journal: Hemoglobin ISSN: 0363-0269 Impact factor: 0.849